Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma PDAC Intensely Increasing

PALM BEACH, Fla., Oct. 23, 2023 /PRNewswire/ — Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignancy of both the digestive system and endocrine system with disappointing prognoses. The number of newly diagnosed PDAC cases worldwide is approaching five million each year. As the seventh leading cause of cancer-related deaths, PDAC…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *